ECRINS THERAPEUTICS
Ecrins Therapeutics is a privately held biotech company specialized in the discovery and development of innovative oncology drugs. Our main drug candidate ET-D5 is being developped for human and veterinary oncology applications and is currently in the regulatory preclinical phase. Our other R&D programs are in the discovery phase.
ECRINS THERAPEUTICS
Industry:
Biotechnology Life Science Veterinary
Founded:
2010-01-01
Address:
Grenoble, Rhone-Alpes, France
Country:
France
Website Url:
http://www.ecrins-therapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.67 M USD
Technology used in webpage:
SPF IPv6 Google Maps ReCAPTCHA Google Maps API ReCAPTCHA V2 Infomaniak Network Infomaniak Mail
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Tierra Biosciences
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Founder
Investors List
Eurostars
Eurostars investment in Grant - Ecrins Therapeutics
Official Site Inspections
http://www.ecrins-therapeutics.com
- Host name: 192.64.119.140
- IP address: 192.64.119.140
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Ecrins Therapeutics"
About Us | ecrins-therapeutics
Created in 2010 with the support of the “Grenoble Alpes Incubation” (“GRAIN”) business incubator, Ecrins Therapeutics is a spin-off from the Grenoble Institute of Neurosciences and …See details»
Home | ecrins-therapeutics
Ecrins Therapeutics is a privately held biotech company specialized in the discovery and development of innovative oncology drugs. Our main drug candidate ET-D5 is being …See details»
Ecrins Therapeutics - Crunchbase Company Profile & Funding
Ecrins Therapeutics is a privately held biotech company specialized in the discovery and development of innovative oncology drugs. Our main drug candidate ET-D5 is being …See details»
Ecrins Therapeutics 2025 Company Profile: Valuation, Funding ...
Ecrins Therapeutics’s primary industry is Biotechnology. Is Ecrins Therapeutics a private or public company? Ecrins Therapeutics is a Private company. What is Ecrins Therapeutics’s current …See details»
Ecrins Therapeutics - 2025 Company Profile - Tracxn
5 days ago Ecrins Therapeutics - Small molecule drug candidates against several oncology indications in humans and domestic animals.. Raised a total funding of $596K over 1 round. …See details»
ECRINS THERAPEUTICS - Societe.com
Jul 21, 2010 ECRINS THERAPEUTICS, société par actions simplifiée, au capital social de 147664,90 EURO, dont le siège social est situé au 5 AVENUE DU GRAND SABLON, 38700 …See details»
Ecrins Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name ... May 11, 2015: Equity Crowdfunding - Ecrins Therapeutics — obfuscated. obfuscated …See details»
Ecrins Therapeutics - Overview, News & Similar companies
Ecrins Therapeutics aims to develop ET-D5 for the treatment of cancer in dogs, and to put this new therapy on the market. For this, Ecrins Therapeu tics launched two projects: In 2015, …See details»
Ecrins Therapeutics Company Profile - Office Locations ... - Craft
Ecrins Therapeutics is a biotechnology company that focuses on the discovery and development of anti-cancer compounds. Its product ET-D5 is a small molecule active against several …See details»
Ecrins Therapeutics - LinkedIn
Ecrins Therapeutics | 790 followers on LinkedIn. Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the …See details»
Ecrins Therapeutics - VentureRadar
Ecrins Therapeutics is a biotech company that develops a first-in-class small molecule drug candidate against several oncology indications in humans and domestic animals. Our lead …See details»
Ecrins Therapeutics - EuroQuity
About your organization / profile Ecrins Therapeutics is developing a wide-ranging portfolio of anti-cancer products. Our compounds target tumors by several different mechanisms and are …See details»
Société ECRINS THERAPEUTICS : Chiffre d'affaires, statuts
Mar 17, 2025 ECRINS THERAPEUTICS à LA TRONCHE (38700) : Bilans, statuts, chiffre d'affaires, dirigeants, actionnaires, levées de fonds, annonces légales, APE, NAF, TVA, RCS ...See details»
Ecrins Therapeutics - Products, Competitors, Financials, Employees ...
Ecrins Therapeutics SAS Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250. Oct 19, 2018. 21:58 EDT 18 Oct 2018 | BioPortfolio Reports …See details»
Ecrins Therapeutics – Auvergne-Rhône-Alpes Network for Drug …
Incorporated in July 2010, Ecrins Therapeutics put in place an original and disruptive drug discovery platform allowing to discover and develop patentable molecules directed against …See details»
Ecrins Thérapeutics SAS - Drug pipelines, Patents, Clinical trials ...
Explore Ecrins Thérapeutics SAS with its drug pipeline, therapeutic area, technology platform, 1 literature, Drug:ET-099, ET-100, ET-058, ET-025, ET-088. Products. Data. Feature. ... The …See details»
science | ecrins-therapeutics
Prior to the creation of Ecrins Therapeutics, the founders of the company, working at Inserm (French National Institute of Health and Medical Research), and in collaboration with chemists …See details»
Ecrins Therapeutics - Company Profile & Staff Directory - ContactOut
Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical …See details»
Le baromètre des startups industrielles françaises par CSI France ...
Ecrins Therapeutics is a biotechnology company which focuses on the discovery and development of novel anti-cancer compounds from the preclinical phase to phase II clinical …See details»
Ecrin Therapeutics, start-up basée près de Grenoble, lève 535 000€ …
May 6, 2015 La société grenobloise Ecrins Therapeutics a levé 535.000 euros sur la plateforme de financement participatif Crowd Avenue, en vue de développer un nouveau médicament …See details»